Loading
Loading…
Loading…
Tender ID
| # | Company | Status |
|---|---|---|
| 1 | Accepted-Technical 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 | BANGALORE | BANGALORE | KARNATAKA | 560045 | Accepted-Technical Accepted |
Tender Value
Refer Docs
EMD Value
₹2.6 Cr
Closing Date
17 Apr 2026, 10:00 amClosed
DDG (Prov), O/o DGAFMS
DDG(Prov) O/o DGAFMS Ministry of Defence 5th Floor, A Block, Defence Offices Complex Africa Avenue New Delhi 110023
Supply of PVMS No 011772, Inj Human Insulin Analogue Aspart Premix 30 percent Insulin / 70 percent Insulin Protamine Aspart suspension 100 IU/ml (Monocomponent Insulin,recombinant DNA origin) 3 ml PFS / PFP
2026_ARMY_757635_1
RC/25-26/368
Single
Drugs and Pharmaceutical Products
Buy
45 days
New Delhi
As per RFP
6 documents required · 6 mandatory
₹0
₹2.6 Cr
Yes
30 Apr 2026
27 Mar 2026
17 Apr 2026
27 Mar 2026
17 Apr 2026
2 Apr 2026
27 Mar 2026 - 2 Apr 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1PVMS No 011772, Inj Human Insulin Analogue Aspart Premix 30% Insulin / 70% Insulin Protamine Aspart suspension 100 IU/ml (Monocomponent Insulin,recombinant DNA origin) 3 ml PFS / PFP | |||||
stage.html
html • 0.02 MB
tech_bid_open.pdf
tech_eval.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.04 MB
Tendernotice_1.pdf
PDF • 0.29 MB
AdditionalInfoOnGST.xls
Additional Documents • 0.03 MB
AdditionalDocument.pdf
Additional Documents • 0.16 MB
RFP.pdf
Tender Documents • 0.74 MB
BOQ_848659.xls
BOQ • 0.25 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .